Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
Why Editas Medicine Was Winning on Wednesday
August 03, 2022
Tickers
EDIT
Tags
Recent Press Releases
EDIT
Market News
From
Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
VNDA
Movers
HZNP
From
Benzinga
Editas Medicine: Q2 Earnings Insights
August 03, 2022
Tickers
EDIT
Tags
EDIT
Market News
Benzinga
From
Benzinga
Down 35% This Year, Is This Small-Cap Stock a Buy?
July 21, 2022
Tickers
BLUE
CRSP
EDIT
NTLA
Tags
NTLA
CRSP
EDIT
From
Motley Fool
The 3 Leaders of the Gene Editing Revolution
July 08, 2022
Tickers
BEAM
BIIB
CRSP
EDIT
Tags
NASDAQ:VRTX,NASDAQ:EDIT,NASDAQ:BEAM,NASDAQ:REGN,NASDAQ:NTLA,NASDAQ:CRSP,NASDAQ:BIIB
REGN
EDIT
From
InvestorPlace
7 Moonshot Investments Upending a $10 Trillion Industry
July 08, 2022
Tickers
AMZN
BEAM
BIIB
CRSP
Tags
BIIB
NTLA
Market News
From
InvestorPlace
Why Shares of Bluebird Bio, CRISPR Therapeutics, and Editas Medicine Soared This Week
July 08, 2022
Tickers
BLUE
CRSP
EDIT
VRTX
Tags
Recent Press Releases
VRTX
CRSP
From
Motley Fool
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
EDIT
Briefs
Price Target
From
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Tickers
ADVM
AIKI
DCTH
DNA
Tags
JAZZ
DNA
Rupert D'Souza
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 07, 2022
Tickers
AIKI
BAOS
BCAN
CETX
Tags
GTLB
EDIT
OBSV
From
InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
June 07, 2022
Tickers
AERC
AUVI
BCAN
CETX
Tags
ENOB
TRMR
Pre/Market Movers
From
Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Tickers
ARKG
ARKK
BNR
DNA
Tags
DNA
ARKK
EDIT
From
InvestorPlace
Editas Medicine's Return On Capital Employed Insights
May 19, 2022
Tickers
EDIT
Tags
EDIT
Market News
Benzinga
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
Recent Press Releases
EDIT
CRSP
From
Motley Fool
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
BMY
Biotech
Trading Ideas
From
Benzinga
These 5-Stock Samplers Have Gotten Whacked. And That's OK
May 13, 2022
Tickers
AAPL
ABNB
AMGN
AMZN
Tags
CRSP
NVTA
LVGO
From
Motley Fool
Expert Ratings for Editas Medicine
May 09, 2022
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Market News
From
Benzinga
Editas Medicine: Q1 Earnings Insights
May 04, 2022
Tickers
EDIT
Tags
BZI/Recaps
News
EDIT
From
Benzinga
Editas Medicine Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EDIT
Tags
News
BZI/CONF
Benzinga
From
Benzinga
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
April 26, 2022
Tickers
EDIT
Tags
Market News
Health Care
Benzinga
From
Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
NTLA
EDIT
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
EDIT
Market News
CRSP
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
NTLA
SFIX
Market News
From
Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
Tags
Legal
EDIT
Briefs
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
RGNX
JAZZ
Earnings
From
Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Tickers
AREB
ATXI
AVGR
AVIR
Tags
DDD
Pre/Market Outlook
SECO
From
Benzinga
Expert Ratings For Editas Medicine
February 25, 2022
Tickers
EDIT
Tags
EDIT
Analyst Ratings
Market News
From
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
Biotech
COLL
ADGI
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
OPK
MRK
NVTA
From
Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
Tickers
AA
ALJJ
AMZN
ANGH
Tags
Markets
PTON
JOBY
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.